SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GENZYME - THE KING OF THE BIOTECHS
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aliveinsf who wrote (266)3/18/1998 10:00:00 AM
From: H. Bradley Toland, Jr.  Read Replies (1) of 410
 
There were times when Genz looked cheap to us and times not. Our cost basis is mid teens. Obviously, if you buy stock A and B and A outperforms B, you should not have purchased B; hindsight is 20-20. Going forward, though, we feel Genz can grow alot if Seprafilm is as big as company thinks it will be. And there are other products coming on line shortly also. So, don't through the towel in just yet.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News